The Effect of Seed Cycling-Based Nutritional Intervention on Premenstrual Symptoms
Evaluation of the Effect of Seed Cycling on Premenstrual Symptoms in Healthy Adults
1 other identifier
observational
48
1 country
1
Brief Summary
This study aims to investigate the effects of the seed-cycling intervention on premenstrual symptoms and nutritional status. At the beginning of the study, written informed consent will be obtained from all individuals who agree to participate. During the month prior to the intervention, participants' menstrual cycles will be monitored to determine their menstrual phases. In this period, dietary intake records and menstrual symptoms will be documented, and the estimated ovulation date will be determined based on reported symptoms. After identifying the participants' follicular phase (approximately days 1-14) and luteal phase (approximately days 15-28), the intervention will be implemented for three consecutive months. Participants will be instructed to consume flaxseed and pumpkin seeds daily during the follicular phase, and sesame seeds and sunflower seeds daily during the luteal phase. The oilseeds to be consumed will be provided to the participants at the beginning of each month in vacuum-sealed single-use packages.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 20, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 20, 2026
CompletedFirst Submitted
Initial submission to the registry
May 4, 2026
CompletedFirst Posted
Study publicly available on registry
May 8, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 20, 2027
ExpectedMay 8, 2026
March 1, 2026
Same day
May 4, 2026
May 4, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Assessment of Premenstrual Syndrome Scale at the beginning and End of the Study
To evaluate the severity of symptoms experienced during the premenstrual period, the Premenstrual Syndrome Scale, a validated instrument, will be administered during the premenstrual weeks of the first and fourth months. The Premenstrual Syndrome Scale is a self-report measure developed to assess the physical, emotional, and behavioral symptoms experienced by women during the luteal phase of the menstrual cycle. The scale consists of a total of 44 items and comprises nine subdimensions. Each item is rated on a five-point Likert scale. Higher total scores obtained from the scale indicate greater severity of premenstrual symptoms. Subdimension scores may be calculated separately, and an overall assessment can also be conducted based on the total score.
The premenstrual weeks of the first and fourth months of the study
Secondary Outcomes (2)
Assessment of Dietary Diversity Score at the Beginning and End of the Study
At the beginning of the first month and at the end of the fourth month of the study
Assessment of Composite Dietary Antioxidant Index at the Beginning and End of the Study
At the beginning of the first month and at the end of the fourth month of the study
Interventions
After identifying the participants' follicular phase (approximately days 1-14) and luteal phase (approximately days 15-28), they will consume specific seeds daily for three consecutive months. During the follicular phase, participants will consume flaxseed and pumpkin seeds per day. During the luteal phase, they will consume sesame seeds and sunflower seeds per day. The oilseeds to be consumed will be provided to the participants at the beginning of each month in vacuum-sealed, single-use packages. Participants with a compliance rate of less than 80% will be excluded from the study.
Eligibility Criteria
Healthy female volunteers between the ages of 18 and 35 years
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Erciyes University
Kayseri, MELİKGAZİ, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
ARMAĞAN AYTUĞ YÜRÜK, Principal Investigator
TC Erciyes University
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant professor
Study Record Dates
First Submitted
May 4, 2026
First Posted
May 8, 2026
Study Start
March 20, 2026
Primary Completion
March 20, 2026
Study Completion (Estimated)
March 20, 2027
Last Updated
May 8, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared due to participant privacy and confidentiality concerns